BioNTech SE (BNTX)
85.04
-2.61
(-2.98%)
USD |
NASDAQ |
Nov 12, 16:00
84.66
-0.38
(-0.45%)
After-Hours: 06:39
BioNTech Price : 85.04 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 86.70 | 86.97 | 84.80 | 85.04 | 979096.0 |
| Nov 11, 2026 | 87.18 | 87.73 | 86.09 | 87.65 | 766155.0 |
| Nov 10, 2026 | 87.10 | 88.08 | 86.39 | 87.21 | 693534.0 |
| Nov 09, 2026 | 87.76 | 88.78 | 86.56 | 87.51 | 1.143M |
| Nov 06, 2026 | 85.60 | 87.94 | 84.89 | 87.51 | 724190.0 |
| Nov 05, 2026 | 90.83 | 90.88 | 85.80 | 85.86 | 1.191M |
| Nov 04, 2026 | 89.24 | 91.46 | 88.25 | 90.70 | 1.353M |
| Nov 03, 2026 | 89.65 | 89.88 | 86.44 | 86.92 | 1.152M |
| Nov 02, 2026 | 88.20 | 88.74 | 87.20 | 87.53 | 709983.0 |
| Oct 30, 2026 | 89.22 | 90.32 | 87.44 | 88.17 | 631915.0 |
| Oct 29, 2026 | 88.50 | 89.66 | 87.77 | 89.13 | 692715.0 |
| Oct 28, 2026 | 86.52 | 88.19 | 85.81 | 87.99 | 870560.0 |
| Oct 27, 2026 | 86.19 | 87.27 | 85.00 | 87.06 | 1.077M |
| Oct 26, 2026 | 86.00 | 88.87 | 85.85 | 86.86 | 1.407M |
| Oct 23, 2026 | 89.34 | 89.86 | 87.52 | 88.12 | 838703.0 |
| Oct 22, 2026 | 90.75 | 92.73 | 89.03 | 89.67 | 1.164M |
| Oct 21, 2026 | 91.25 | 92.35 | 91.02 | 91.29 | 1.113M |
| Oct 20, 2026 | 89.50 | 91.44 | 88.56 | 91.17 | 1.836M |
| Oct 19, 2026 | 88.10 | 89.80 | 87.72 | 89.21 | 1.343M |
| Oct 16, 2026 | 90.14 | 90.14 | 87.36 | 87.71 | 1.104M |
| Oct 15, 2026 | 88.92 | 90.72 | 88.45 | 90.20 | 1.080M |
| Oct 14, 2026 | 89.01 | 90.50 | 88.57 | 88.66 | 1.131M |
| Oct 13, 2026 | 92.36 | 93.08 | 88.85 | 89.01 | 1.952M |
| Oct 12, 2026 | 97.61 | 98.60 | 95.75 | 95.84 | 1.277M |
| Oct 09, 2026 | 92.45 | 97.40 | 92.30 | 96.96 | 1.320M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biodexa Pharmaceuticals Plc | 2.38 |
| Moderna, Inc. | 231.35 |
| Mereo BioPharma Group Plc | 0.305 |
| NuCana Plc | 0.93 |
| Immatics NV | 6.52 |
Price Related Metrics
| PS Ratio | 7.607 |
| PEG Ratio | -0.0768 |
| Price to Book Value | 1.048 |
| Earnings Yield | -8.08% |
| Market Cap | 21.08B |
| PEGY Ratio | -0.0768 |